Item
D-xylose corn (1039)
D-Xylose 100% Main component
Food Ingredient
Locations
Location name | Address |
---|---|
Futaste Pharmaceutical Co. Ltd | No.666, Nanhuan Road Yucheng City, Shandong Province 000000 CHN |
PRINOVA EUROPE LIMITED | 10 ALDERSGATE STREET LONDON, LONDON EC1A 4HJ GBR |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | Futaste Pharmaceutical Co. Ltd | Allergens.pdf | 5/30/2019 | 5/29/2021 |
CoA Sample | PRINOVA EUROPE LIMITED | Approved COA Template.pdf | 10/16/2017 | 10/16/2019 |
BSE - TSE | PRINOVA EUROPE LIMITED | BSE-TSE.pdf | 10/8/2018 | 10/7/2021 |
Pesticide | PRINOVA EUROPE LIMITED | Contaminants and Impurities.pdf | 10/8/2018 | 10/7/2020 |
Country of Origin | Futaste Pharmaceutical Co. Ltd | Country of Origin.pdf | 5/30/2019 | 5/29/2022 |
CoA Sample | Futaste Pharmaceutical Co. Ltd | D-Xylose 1039 Futaste Pharmaceutical - COA.pdf | 2/4/2020 | 2/3/2022 |
GMO | Futaste Pharmaceutical Co. Ltd | D-Xylose 1039 Futaste Pharmaceutical - GMO Status Issue CH01.pdf | 2/4/2020 | 7/18/2021 |
Natural | Futaste Pharmaceutical Co. Ltd | D-Xylose 1039 Futaste Pharmaceutical - Natural Status Issue CH01 Amended.pdf | 2/4/2020 | 7/17/2021 |
Safety Data Sheet (SDS) | Futaste Pharmaceutical Co. Ltd | D-XYLOSE 1039 SDS Ver 1.0 English 2019.pdf | 6/6/2019 | 6/5/2021 |
Kosher | Futaste Pharmaceutical Co. Ltd | Futaste - Kosher Certificate Mar 27 2020.pdf | 2/4/2020 | 3/27/2020 |
Halal | PRINOVA EUROPE LIMITED | Halal Certificate.pdf | 6/19/2018 | 6/18/2021 |
Kosher | PRINOVA EUROPE LIMITED | Kosher Certificate.pdf | 3/27/2018 | 3/27/2019 |
Natural | PRINOVA EUROPE LIMITED | Natural Status.pdf | 10/8/2018 | 10/8/2019 |
Nutrition | Futaste Pharmaceutical Co. Ltd | Nutrition.pdf | 2/4/2020 | 7/18/2021 |
Organic | PRINOVA EUROPE LIMITED | Organic Compliance.pdf | 9/29/2016 | 9/29/2019 |
Heavy Metal | PRINOVA EUROPE LIMITED | Specification - Factory.pdf | 11/8/2018 | 11/7/2020 |
Product Specification Sheet | PRINOVA EUROPE LIMITED | Specification - Factory.pdf | 11/8/2018 | 11/7/2021 |
Suitability Requirements | Futaste Pharmaceutical Co. Ltd | Suitability Requirements.pdf | 5/30/2019 | 5/29/2022 |